New Zealand Personal Products Stock News

Contract announcement puts Infratil in focus Infratil (NZSE:IFT) has drawn fresh investor attention after announcing a new contract and scheduling a special call to explain how the agreement could influence its future revenue profile and operations. See our latest analysis for Infratil. The contract announcement sits alongside strong recent share price momentum, with a 1 day share price return of 13.23% and a 30 day share price return of 26.74%, while the 5 year total shareholder return of...

Meridian Energy was recently added to S&P Dow Jones’ Best-in-Class World Index, placing it among the top 10% of utilities worldwide for organisational resilience, governance, and ESG transparency. As the only New Zealand company in this index, Meridian’s inclusion highlights its distinct position in global sustainability benchmarks and its appeal to ESG-focused stakeholders. We’ll now examine how Meridian’s Best-in-Class World Index status may influence its investment narrative around ESG...

Wondering if Fisher & Paykel Healthcare, at around its recent price of $35.75, is offering fair value or if you would be overpaying for growth potential. The stock has been relatively muted in the short term, with returns of 1.1% over the last year, a 5.1% decline year to date, and smaller pullbacks of 1.4% over 7 days and 2.6% over 30 days. These moves have kept Fisher & Paykel Healthcare on many watchlists, as investors weigh its long term track record of 40.7% over 3 years and 17.0% over...

In early May 2026, The a2 Milk Company voluntarily recalled three batches of its imported a2 Platinum Premium USA label infant formula sold in the United States after detecting cereulide, a heat‑stable toxin, advising customers to stop using the product and return it for a refund, despite no confirmed illnesses. An interesting aspect is that the affected infant formula line had already been discontinued and removed from sale before the recall, raising questions about how a past quality issue...

Analyst and investor day puts recent geopolitical risks in focus Summerset Group Holdings (NZSE:SUM) held an Analyst and Investor Day to update the market on how operations and performance are tracking after the outbreak of conflict in the Middle East at the end of February. See our latest analysis for Summerset Group Holdings. At a share price of NZ$8.04, the stock has faced a 30.0% 3-month share price return decline and a 35.1% year-to-date share price return decline, while the 3-year total...

Auckland International Airport (NZSE:AIA) is back in focus after CEO Carrie Hurihanganui publicly raised concerns about aviation competition in New Zealand and reported a 15% rise in aeronautical revenues following the end of a Covid-era price freeze. See our latest analysis for Auckland International Airport. At a share price of NZ$8.37, Auckland International Airport has recorded a 1 day share price return of 1.45% and a 30 day share price return of 3.72%, while the 1 year total shareholder...

What the latest operating update tells you about Vector Vector (NZSE:VCT) released unaudited operating results for the nine months to 31 March 2026. The update highlighted higher electricity customers, more new electricity connections and greater electricity volume distributed, alongside slightly softer gas distribution metrics. See our latest analysis for Vector. Set against the latest operating update, Vector’s share price has had a modest uplift recently, with a 30 day share price return...

Recent projections for strong growth in China’s baby food market, driven by higher disposable incomes, urbanization, and a rising focus on infant nutrition, put a2 Milk (NZSE:ATM) firmly in the spotlight as one of the sector’s key players. See our latest analysis for a2 Milk. a2 Milk’s share price has recently been under pressure, with a 30 day share price return of 20.18% decline and a year to date share price return of 17.13% decline, even as the 3 year total shareholder return sits at...

Fisher & Paykel Healthcare (NZSE:FPH) is back in focus after recent share price moves, with the stock showing a 0.7% decline over the past day and softer returns over the past month. See our latest analysis for Fisher & Paykel Healthcare. While the 1-day share price return of 0.72% and 7-day share price return of 5.80% point to softer short term momentum, the 1-year total shareholder return of 5.57% and 3-year total shareholder return of 34.95% indicate that longer term holders have still...

Genesis Energy has confirmed it reached a Final Investment Decision on 17 April 2026 for Stage 2 of its Battery Energy Storage System at Huntly Power Station, committing roughly NZ$106 million to add 100MW / 200MWh of consented, grid-connected capacity by the third quarter of fiscal 2028. This expansion, funded on balance sheet after a recent NZ$400 million equity raise, is positioned as New Zealand’s lowest-cost committed grid-scale BESS to date and a key milestone in Genesis’ Gen35 growth...

Genesis Energy (NZSE:GNE) has committed to a second stage of battery storage at Huntly Power Station, approving a 100MW / 200MWh expansion that supports its Gen35 plan and shift away from baseload gas. See our latest analysis for Genesis Energy. The Huntly BESS expansion comes as Genesis Energy’s 1 month share price return of 8.8% and 7 day return of 4.4% contrast with a year to date share price decline of 2.1%. At the same time, the 1 year total shareholder return of 17.1% and positive 3...

Readers hoping to buy Scott Technology Limited ( NZSE:SCT ) for its dividend will need to make their move shortly, as...

As Asian markets navigate a landscape marked by geopolitical developments and economic data releases, small-cap stocks are capturing attention with their potential for growth amid broader market movements. In this context, insider buying can serve as a valuable indicator of confidence in these companies' prospects, offering insights into which stocks might be positioned to capitalize on current conditions.

Ryman Healthcare Limited reported that total sales of occupation right agreements for retirement village units rose to 331 in the fourth quarter ended 31 March 2026, up from 302 a year earlier. This lift in quarterly unit sales points to firmer demand for Ryman’s retirement village offering, an important indicator for ongoing village occupancy and cash generation. We’ll now examine how this stronger fourth-quarter unit sales performance shapes Ryman Healthcare’s investment narrative and...

Ryman Healthcare (NZSE:RYM) has drawn investor attention after reporting fourth quarter sales of 331 occupation right agreements for retirement village units, compared with 302 a year earlier, in its latest trading statement. See our latest analysis for Ryman Healthcare. The trading update comes after a mixed run in the share price, with a 3.98% 1 day share price return and a 0.97% 7 day share price return, set against a 27.93% 90 day share price decline and a 57.76% 3 year total shareholder...

Why Fonterra’s CEO Change Matters For Shareholders Fonterra Co-operative Group (NZSE:FCG) has announced that long-time executive Richard Allen will become CEO on May 1, 2026, with outgoing chief Miles Hurrell staying on as an adviser until September. This internal appointment, following Allen’s senior roles across ingredients, foodservice, Farm Source and international operations, keeps attention on how leadership continuity might influence Fonterra’s scale, capital allocation and dividend...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Scott Technology (NZSE:SCT) H1 2026 earnings snapshot Scott Technology (NZSE:SCT) has reported fresh numbers for H1 2026, with revenue of NZ$153.5 million and basic EPS of NZ$0.119, alongside net income of NZ$10.0 million. Over recent halves the company recorded revenue of NZ$135.3 million in H2 2024, NZ$121.7 million in H1 2025 and NZ$153.5 million in H2 2025. Over the same periods, basic EPS moved from NZ$0.0418 to NZ$0.054 and then to NZ$0.119, making this release a useful check on how...

Meridian Energy (NZSE:MEL) has just completed an A$400 million issue of fixed rate green medium term notes, a funding move that ties directly to future investment in qualifying green assets. See our latest analysis for Meridian Energy. At a share price of NZ$5.56, Meridian’s recent 2.02% 1 day gain contrasts with a modest 0.71% year to date share price decline. Its 3 year total shareholder return of 22.35% points to steadier long run compounding. The oversubscribed A$400 million green note...

We feel now is a pretty good time to analyse Serko Limited's ( NZSE:SKO ) business as it appears the company may be on...

Warehouse Group (NZSE:WHS) has just posted its H1 2026 scorecard, with trailing twelve month revenue of NZ$3.1b and basic EPS of NZ$0.003, while the latest reported half year, H2 2025, showed revenue of NZ$1,479.5 million and a net income loss of NZ$14.6 million. Over recent halves, revenue has moved from NZ$1,404.9 million in H2 2024 to NZ$1,607.2 million in H1 2025 and then to NZ$1,479.5 million in H2 2025, with EPS swinging between a loss of NZ$0.074, a profit of NZ$0.034, and a loss of...

Hallenstein Glasson Holdings (NZSE:HLG) has kicked off H1 2026 reporting with trailing 12 month revenue of NZ$505.9 million and basic EPS of NZ$0.78, set against a year where earnings grew 33.9% and the net margin was 9.1%. The company has seen revenue move from NZ$452.7 million to NZ$505.9 million over the last three trailing periods, while basic EPS stepped from NZ$0.58 to NZ$0.78. This gives a clear view of how sales and profits are tracking into the latest half. With that backdrop of...

Q2 2026 earnings snapshot Fonterra Co-operative Group (NZSE:FCG) has just put fresh numbers on the table, with the latest reported quarter showing revenue of NZ$4.4 billion and a basic EPS loss of NZ$0.10, set against a trailing twelve month EPS of NZ$0.62 and revenue of NZ$24.1 billion. Over recent periods the co operative has seen quarterly revenue range from NZ$3.4 billion to NZ$7.1 billion, while basic EPS has swung between a loss of NZ$0.10 and a profit of NZ$0.25, giving investors a...

Synlait Milk (NZSE:SML) has put fresh numbers on the table for H1 2026, with revenue of about NZ$910.6 million and basic EPS of a loss of NZ$0.07, alongside net income of a loss of NZ$44.6 million. The company has seen revenue move from NZ$843.3 million in H2 2024 to NZ$916.8 million in H1 2025 and NZ$910.6 million in H2 2025. EPS has shifted from a loss of NZ$0.39 in H2 2024 to EPS of NZ$0.01 in H1 2025 and back to a loss of NZ$0.07 in H2 2025, presenting a picture where top line scale is...